United Therapeutics Company
United Therapeutics Corporation is an American publicly traded biotechnology companyt hat focuses on develop novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
Investor Type:
N/A
Technology:
COVID-19 Investors
Investment Stage:
N/A
Estimated Revenue:
$100M to $500M
Founded Date:
1996-01-01
Industry:
Altered Signaling
Employee Number:
501-1000
Funding Status:
IPO
Number Of Exists:
N/A
Headquarters:
United States